Trazodone-related oromandibular dyskinesia.

Dyskinesia oromandibular trazodone

Journal

Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 13 04 2023
revised: 04 12 2023
accepted: 06 12 2023
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 13 5 2024
Statut: ppublish

Résumé

This is a report of a series of three cases of trazodone-induced oral lingual dyskinesias. Each case demonstrated a distinct pattern of the development of this dyskinesia after trazodone exposure for several months. All cases showed abrupt cessation of the movement disorder when the drug was discontinued. Two of the three cases had no prior exposure to any dopamine-blocking agents. One of the three had a distant exposure to a dopamine antagonist. Trazodone has a mechanism of action that can account for both the development and treatment of dyskinetic movements. This article will discuss proposed mechanisms for trazodone's action with an emphasis on case reports of dystonic movements being more prevalent in the elderly.

Identifiants

pubmed: 38736787
doi: 10.4103/jfmpc.jfmpc_645_23
pii: JFMPC-13-1103
pmc: PMC11086781
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1103-1105

Informations de copyright

Copyright: © 2024 Journal of Family Medicine and Primary Care.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Auteurs

Alan L Schneider (AL)

Department of Psychiatry, Keck School of Medicine, University of Southern California, Newport Beach, CA, United States.

Classifications MeSH